From June 11th, the list of brand name medicines borne by the Fund will be expanded with 80 new brand name medicines from 23 different manufacturers1 and companies, within the existing generics which will be 4% more medicines for the insureds. With this, the total count of medicines from different manufacturers available for the insureds and borne by the Fund is 2010 medicines or 52% of the registered medicines in the country.